Utilization of the Impella for hemodynamic support during percutaneous intervention and cardiogenic shock: an insight

Authors

Document Type

Article

Abstract

Impella is a catheter-based micro-axial flow pump placed across the aortic valve, and it is currently the only percutaneous left ventricular assist device approved for high-risk percutaneous coronary intervention and cardiogenic shock. Areas Covered: Even though several studies have repeatedly demonstrated the excellent hemodynamic profile of Impella in high-risk settings, it remains underutilized. Here we aim to provide an up-to-date summary of the available literature on Impellas use in High risk settings as well as the practical aspects of its usage. Expert Commentary: Percutaneous coronary interventions in high rsk settings have always been challenging for a physician. Impella 2.5 and CP, have been proven safe, cost effective and feasible in High Risk Percutaneous coronary Interventions with an excellent hemodynamic profile.

Medical Subject Headings

Contraindications, Procedure; Cost-Benefit Analysis; Heart-Assist Devices (adverse effects); Hemodynamics; Humans; Medical Illustration; Percutaneous Coronary Intervention (instrumentation, methods); Shock, Cardiogenic (therapy)

Publication Date

10-1-2017

Publication Title

Expert review of medical devices

E-ISSN

1745-2422

Volume

14

Issue

10

First Page

789

Last Page

804

PubMed ID

28862481

Digital Object Identifier (DOI)

10.1080/17434440.2017.1374849

Share

COinS